In light of the conviction of UK nurse Lucy Letby for murder, doctors are callin...
Patient data sharing among various stakeholders for research purposes forms the ...
Merck (MSD) and AstraZeneca have received approval in Japan for Lynparza to trea...
The Sandoz biosimilar, Tyruko, was approved by the US FDA for all labelled indic...
The latest fundraise will close in 2024, with plans for one Phase II trial to st...
Soliris is already approved to treat refractory generalised myasthenia gravis in...
GOP candidates debated over just how far the party should go on national abortio...
Good morning, Pharmalittle readers. Reporter Andrew Joseph here filling in for E...
Drugmakers already bet big on mRNA for cancer. So why is Biden's new health agen...
Medical professionals often find it very difficult to seek medical care for them...
If last month's price hikes are any indication, the Medicare rebate provisions i...
To be useful to patient and providers, rating systems must move past monolithic ...
We can’t know what the future will look like for weight loss drugs. But in medic...
Vivek Ramaswamy’s brashness made waves in the Republican debate — much as it did...
Neumora, a neuroscience startup founded by VC Arch Venture Partners, hopes to be...
A research team has discovered a genetic variant that increases the risk of Park...